Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

EMA validates Pfizer and Valneva’s Lyme disease vaccine | PharmaVoice

Pharma Tech

EMA validates Pfizer and Valneva’s Lyme disease vaccine

Aug 17, 2026, 9:20 AM

Read Full Article → EMA validates Pfizer and Valneva’s Lyme disease vaccine

EMA validates Pfizer and Valneva’s Lyme disease vaccine

Translate article text

Choose a language and wait for the translated text.

The EMA has validated the MAA from Pfizer and Valneva for their Lyme disease vaccine candidate, PF-07307405.